期刊文献+

肝硬化患者肠外营养时甘油三酯的代谢研究 被引量:3

下载PDF
导出
摘要 目的 :观察中、长链脂肪乳剂对肝硬化患者甘油三酯代谢的影响。方法 :16例肝硬化患者随机分成两组 ,给予肠外营养 (简称 PN ) ,长链脂肪乳剂组 (简称 L CT组 ,n=8)。中 /长链混合脂肪乳剂组 (简称 ML CT组 ,n=8)。两组PN所含非蛋白热量及氮量均相等。对照组选取肝功能正常、无糖尿病、无高血脂的非肝硬化患者 16例 ,随机分为两组。结果 :在输注等量的两种脂肪乳剂后 ,ML CT组甘油三酯含量即高于 L CT组 (P<0 .0 1) ,随后明显下降。无论对照组或实验组 ,ML CT组甘油三酯 (TG)的 T1 /2 明显优于 L CT组 (P<0 .0 1)。结论 :ML CT乳剂体内清除迅速 ,且不受肝硬化的影响 。
出处 《临床医药实践》 2003年第1期18-19,共2页 Proceeding of Clinical Medicine
  • 相关文献

参考文献9

  • 1[1]Muscaritoli M. Angiano C,Ascino A et al. Oxgenous lipid clearance in onpensated liver cirrhosis[J]. JPEN,1986,10:599.
  • 2[2]Freeman M. Kuiken L. Regland JB et al. Hepatic triglyceride lipase deficiencies in liver disease [J].Lipids, 1997,12 : 443.
  • 3[3]Druml W. Fischer M. pidlich J et al. Fat elimination in chronic hepatic failure: Long- chain vs mediumchain triglycerides[J]. Clin. Nutr, 1995,61 :812.
  • 4[4]Schneeweiss B. Graninger W. Ferencei P et al. Energy metabolisms in patients with acute and chronic liver disease[J]. Hepatology, 1990,11: 387.
  • 5[5]Muller MJ,Lautz HU,Plogmann B et al. energy expenditure and substrate oxidation in patients with cirrhosis:the impact of cause,clinical staging and nutritional state[J]. Hepatology, 1992,15:782.
  • 6[6]Pomposelli TT,Valicenti AJ,Babayan VK et al. medium chain triglycerides (MCT)are effcient energy soures in hepatic insufficiency[J]. JPEN, 1984,8: 88.
  • 7[7]Fan,Facs,Wong J et al. Medium-chain triglycerides in cirrhotic patients[J]. JPEN, 1992,16:279.
  • 8[8]Dawes RFH,Royle GT,Dennision AR et al. Metabolic studies of a lipid emulsion containing medium-chain triglycerides in properative and total parenteral nutrition infulsions[J]. Biochemstry, 1994,33M: 4872.
  • 9[9]Rechelle M, Deckbaom R J, Vanweyenberg V et al.lipoprotein metabolism during and after a 6-hour infusion of MCT/LCT vs LCT emulsion in man [J].Clinical nutrition, 1997,16:119.

同被引文献39

  • 1周丽华,徐礼鲜,马加海,张惠,王惠霞,刘春然.丙泊酚的药效及对脂代谢的影响[J].临床麻醉学杂志,2006,22(5):362-364. 被引量:16
  • 2Nakane M,Iwama H.A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate[J].Br J Anaesth,1999,83:397-404.
  • 3Doenicke A W,Roizen M F,Rau J,et al.Pharmacokinetics and pharmacodynamics of propofol in a new solvent[J].Anesth Analg,1997,85:1399-1403.
  • 4H Suzuki,H Miyazaki,T Andoh.Propofol formulated with long-/medium-chain triglycerides reduces the pain of inject by target controlled infusion[J].Acta Anaesthesiol Scand,2006,50:568-571.
  • 5Durrington F N,Miller J P.Clinical aspects of hyperlipidaemia[J].Br J Hosp Med,1994,23:552-553.
  • 6贺明芳.丙泊酚连续输注对机体血糖、血脂和酸碱平衡的影响.中南大学湘雅医学院学报,2008,25(4):327-330.
  • 7Johnson R C,Cotter R.Metabolism of medium-chain triglyceride lipide mulsion[J].Nutrition International,1986,2:150.
  • 8Gottardis M,Khunl-Brady K S,Koller W,et al.Effect of prolongde sedarion with propofol on serum triglyceride and cholesterol concentrations[J].Br J Anaesth,1989,62(4):393-396.
  • 9Cremer C L,Moons K G,Boumen,et al.Longterm propofol infusion and cardiac in adult head-injured patiens[J].Lancet,2001,357:117-118.
  • 10Parke T J,Stevens J E,Rice A S,et al.Metabolic acidosis and fatal myocardial failure after propofol infusion in children:five case reports[J].Br Med J,1992,305:613-616.

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部